Compare GSK plc (GSK) vs Waste Management, Inc. (WM) Price & Performance

GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.

GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.

WM trades at $242.56, up 3.54% today and near its 52-week high, with a bullish technical signal from moving averages. The company reported $25.20B revenue in 2025, with a net income margin of 10.99%, though recent quarters show mixed EPS performance. Strong cash flow from operations of $6.04B supports dividend payments, including a recent $0.95 per share distribution.

Outlook remains positive with a consensus price target of $264.17, reflecting analyst confidence in WM's pricing power and renewable energy initiatives. Key risks include elevated debt levels and potential economic sensitivity. The stock offers stability with growth potential, but investors should monitor execution against earnings expectations.